4//SEC Filing
Shea Thomas 4
Accession 0001209191-13-014674
CIK 0001333170other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:25 PM ET
Size
16.4 KB
Accession
0001209191-13-014674
Insider Transaction Report
Form 4
Shea Thomas
SVP Manufacturing Operations
Transactions
- Award
Common Stock
2013-03-04+6,952→ 29,021 total - Exercise/Conversion
Common Stock
2013-03-04+2,939→ 31,960 total - Award
Restricted Stock Unit
2013-03-04+8,819→ 8,819 total→ Common Stock (8,819 underlying) - Exercise/Conversion
Restricted Stock Unit
2013-03-04−2,939→ 5,880 total→ Common Stock (2,939 underlying) - Award
Stock Option (right to buy)
2013-03-04+41,186→ 41,186 totalExercise: $11.03From: 2013-03-04Exp: 2023-03-03→ Common Stock (41,186 underlying) - Tax Payment
Common Stock
2013-03-04$11.03/sh−3,557$39,234→ 28,403 total
Footnotes (6)
- [F1]In March 2012, the Compensation Committee of the Board of Directors (the "Compensation Committee") established the NxStage Medical, Inc. (the "Company") 2012 Corporate Bonus Plan with the amount of awards to be determined based upon the satisfaction of 2012 revenue, cash generation and net income targets. On March 4, 2013, the Compensation Committee awarded the reporting person 6,952 shares of common stock based on its evaluation of the achievement of performance criteria established under the 2012 Corporate Bonus Plan.
- [F2]Shares of common stock acquired upon the vesting of restricted stock units pursuant to the Company's 2012 Performance Share Plan.
- [F3]This transaction reflects the withholding of shares of the Company's common stock to satisfy the reporting person's tax liability incurred in connection with the common stock granted to the reporting person on March 4, 2013 pursuant to the Company's 2012 Corporate Bonus Plan and the vesting of the first tranche of restricted stock units (the "Award") on March 4, 2013 pursuant to the Company's 2012 Performance Share Plan.
- [F4]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- [F5]In March 2012, the Compensation Committee established the Company's 2012 Performance Share Plan with the amount of awards to be determined based upon the satisfaction of 2012 revenue, cash generation and net income targets. On March 4, 2013, the Compensation Committee granted the reporting person 8,819 restricted stock units, the Award, based on its evaluation of the achievement of performance criteria under the Company's 2012 Performance Share Plan. The Award vested 33 1/3rd on March 4, 2013, with the balance vesting in two equal installments on March 4, 2014 and March 4, 2015.
- [F6]This stock option vests over four years in 48 equal monthly installments.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeother
Related Parties
1- filerCIK 0001429894
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 6:25 PM ET
- Size
- 16.4 KB